{"id":38693,"date":"2015-02-13T17:04:17","date_gmt":"2015-02-13T21:34:17","guid":{"rendered":"http:\/\/piel-l.org\/blog\/?p=38693"},"modified":"2015-02-13T17:44:28","modified_gmt":"2015-02-13T22:14:28","slug":"intravenous-methylprednisolone-pulse-therapy-in-severe-alopecia-areata","status":"publish","type":"post","link":"https:\/\/piel-l.org\/blog\/38693","title":{"rendered":"Intravenous methylprednisolone pulse therapy in severe alopecia areata"},"content":{"rendered":"<p>Senila SC, Danescu SA, Ungureanu L, Candrea E, Cosgarea RM1.<br \/>\nAuthor information<\/p>\n<p>Abstract<\/p>\n<p>BACKGROUND:<\/p>\n<p>Severe, extensive, therapy resistant alopecia areata represents a clinical challenge. Systemic corticosteroids are a therapeutic tool that still needs to be evaluated.<\/p>\n<p>AIM:<\/p>\n<p>The purpose of this study was to assess the efficacy and safety of methylprednisolone pulse therapy in alopecia areata and to find prognostic factors for a favourable outcome.<\/p>\n<p>METHODS:<\/p>\n<p>A total of 32 patients with severe multifocal alopecia areata (more than 40% scalp hair loss), alopecia totalis, and alopecia universalis were treated with infusions of 500 mg methylprednisolone for 3 days every month for 3 consecutive months. The end point of the study was 12 months.<\/p>\n<p>RESULTS:<\/p>\n<p>Of 32 patients, 26 (81.3%) reported a clinical response. Four patients (12.5%) showed complete hair regrowth, 6 patients (18.8%) showed >50% hair regrowth, ten (31.3%) had <50% hair regrowth, 6 (18.75%) were non responders, and another 6 patients (18.8%) had relapse after an initial regrowth. Multivariate analysis revealed that patients reporting at the first episode and those with multifocal disease had the best results.\n\nCONCLUSION:\n\nMethylprednisolone infusions represent a possible therapeutic option for patients with multifocal alopecia areata\n<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Senila SC, Danescu SA, Ungureanu L, Candrea E, Cosgarea RM1. Author information Abstract BACKGROUND: Severe, extensive, therapy resistant alopecia areata represents a clinical challenge. Systemic corticosteroids are a therapeutic tool that still needs to be evaluated. AIM: The purpose of this study was to assess the efficacy and safety of methylprednisolone pulse therapy in alopecia &hellip;<\/p>\n","protected":false},"author":16,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8,1],"tags":[],"class_list":["post-38693","post","type-post","status-publish","format-standard","","category-articulos-cientificos","category-generales"],"_links":{"self":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/38693","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/comments?post=38693"}],"version-history":[{"count":0,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/38693\/revisions"}],"wp:attachment":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media?parent=38693"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/categories?post=38693"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/tags?post=38693"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}